Zeki AKÇA, Hasan MUTLU, Abdülsamet ERDEN, Abdullah BÜYÜKÇELİK, Emel Yaman SEZER, ALİ İNAL

The Relationship between ABO Blood Group and Glioblastoma Multiforme

Glioblastoma Multiforme (GBM) is the most common type of primary brain tumor and its prognosis is poor. Some studies have investigated the relationship between ABO Blood Groups and cancer risk. In this study we evaluated the patients with GBM and control group regarding ABO Blood Groups. Secondly we compared the progression free survival (PFS) and overall survival (OS) regarding ABO Blood Group in patients with GBM. A total of 72 patients with GBM were enrolled from Mersin Government Hospital, Acibadem Kayseri Hospital and Kayseri Training and Research Hospital between 2006-2012. Healthy donors that were admitted to the Turkish Red Crescent Blood Service in our city in year 2012 were selected as control group. Both of groups were compared regarding ABO Blood Groups. The PFS and OS were evaluated according to ABO Blood Groups in patients with GBM. We did not find any significant difference regarding the ratio of ABO Blood Groups between patients with GBM and control group. And there were no significant difference for PFS and OS among O, A, B, AB groups in patients with GBM. According to our results, comparison of control group with healthy donors and GBM patients, the ratio of blood groups was similar in both. And ABO Blood Groups have no effect on PFS and OS in patients with GBM. Also further studies are needed to explain whether there is any relationship between ABO Blood Group and Glioblastoma Multiforme.

PDF

___

1. Engin H, Bilir C, Üstün H, Gökmen A. ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region. Asian Pac J Cancer Prev. 2012;13(1):131-3.

2. Oguz A, Unal D, Tasdemir A, Karahan S, Aykas F, Mutlu H, Cihan YB, Kanbay M. Lack of any association between blood groups and lung cancer, independent of histology. Asian Pac J Cancer Prev. 2013;14(1):453-6.

3. Utkan G, Ürün Y, Cangir AK, Kılıç D, Özdemir NY, Oztuna DG, Bulut E, Arslan ÜY, Koçer M, Kavukçu Ş, İçli F. Clinicopathological features of patients with malignant mesothelioma in a multicenter, case-control study: no role for ABO-Rh blood groups. Asian Pac J Cancer Prev. 2013;14(1):249-53.

4. Yuzhalin AE, Kutikhin AG.ABO and Rh blood groups in relation to ovarian, endometrial and cervical cancer risk among the population of South-East Siberia. Asian Pac J Cancer Prev. 2012;13(10):5091-6.

5. Wang Z, Liu L, Ji J, Zhang J, Yan M, Zhang J, Liu B, Zhu Z, Yu Y.ABO Blood Group System and Gastric Cancer: A Case-Control Study and Meta-Analysis. Int J Mol Sci. 2012;13(10):13308-21.

6. Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, Cunningham JM, Fridley BL, Gayther SA, Goode EL, Iversen ES, Lissowska J, Palmieri Weber RT, Pharoah PD, Phelan CM, Ramus SJ, Schildkraut JM, Sutphen R, Tsai YY, Tyrer J, Vierkant RA, Wentzensen N, Yang HP, Terry KL, Tworoger SS. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes Control. 2012;23(11):1805-10.

7. Urun Y, Ozdemir NY, Utkan G, Akbulut H, Savas B, Oksuzoglu B, Oztuna DG, Dogan I, Yalcin B, Senler FC, Onur H, Demirkazik A, Zengin N, Icli F. ABO and Rh Blood Groups and Risk of Colorectal Adenocarcinoma. Asian Pac J Cancer Prev. 2012;13(12):6097-100.

8. Braganza MZ, Kitahara CM, Berrington de González A, Inskip PD, Johnson KJ, Rajaraman P. Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol. 2012;14(11):1316-24.

9. Giles GG, McNeil JJ, Donnan G, Webley C, Staples MP, Ireland PD, Hurley SF, Salzberg M Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia.. Int J Cancer. 1994;59(3):357-62.

10. Inskip PD, Mellemkjaer L, Gridley G, Olsen JH.Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control. 1998;9(1):109-16.

11. Chen H, Ward MH, Tucker KL, Graubard BI, McComb RD, Potischman NA, Weisenburger DD, Heineman EF. Diet and risk of adult glioma in eastern Nebraska, United States. Cancer Causes Control. 2002;13(7):647-55.

12. Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, Feychting M, Grimsrud TK.Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst. 2012;104(16):1251-9.

13. Musicco M, Sant M, Molinari S, Filippini G, Gatta G, Berrino F. A case-control study of brain gliomas and occupational exposure to chemical carcinogens: the risk to farmers. Am J Epidemiol. 1988;128(4):778-85.

14. Preston-Martin S. Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County. Neuroepidemiology. 1989;8(6):283-95.

15. Savitz DA, Loomis DP.Magnetic field exposure in relation to leukemia and brain cancer mortality among electric utility workers. Am J Epidemiol. 1995;141(2):123-34.

16. Mehrazin M. ABO blood group frequency and brain tumors. Asian Pac J Cancer Prev. 2006;7(4):582-4.

17. Turowski K, Czochra M. [ABO blood groups in glioblastoma multiforme]. Neurol Neurochir Pol. 1979;13(2):173

18. Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM.ABO blood group and breast cancer incidence and survival. Int J Cancer. 2012;130(9):2129-37.

19. Qiu MZ, Zhang DS, Ruan DY, Luo HY, Wang ZQ, Zhou ZW, Wang FH, Li YH, Xu RH.A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China. Med Oncol. 2011;28 Suppl 1:S268-73.

20. Kos FT, Civelek B, Seker MM, Arik Z, Aksoy S, Uncu D, Ozdemir N, Zengin N.Is There an Association between Blood Group and Survival in Pancreatic Cancer? Asian Pac J Cancer Prev. 2012;13(12):6151-3.

21. Kaffenberger SD, Morgan TM, Stratton KL, Boachie AM, Barocas DA, Chang SS, Cookson MS, Herrell SD, Smith JA, Clark PE.ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma. BJU Int. 2012;110(11 Pt B):E641-6